NuCana (NCNA) Shares Outstanding (2015 - 2025)

NuCana (NCNA) reported Shares Outstanding (Entity) of $210.3 billion for Q2 2022, down 9.84% on a YoY basis from $233.3 billion in Q2 2021, and down 6.13% sequentially from $224.1 billion in Q1 2022.

NuCana (NCNA) Shares Outstanding (2015 - 2025) Analysis & Trends

NuCana (NCNA) has 8 years of Shares Outstanding (Entity) data on file, last reported at $210.3 billion in Q2 2022.

  • For the quarter ending Q2 2022, Shares Outstanding (Entity) fell 9.84% year-over-year to $210.3 billion; the trailing twelve-month figure through Jun 2022 stood at $210.3 billion (down 9.84% YoY), and the FY2021 full-year result was $229.1 billion, up 47.19% from the prior year.
  • Shares Outstanding (Entity) slipped to $210.3 billion in Q2 2022, from $224.1 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $233.3 billion in Q2 2021 to a low of $127.8 billion in Q3 2019.
  • A 5-year average of $166.2 billion and a median of $140.1 billion in 2018 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) surged 79.74% in 2021 and decreased 9.84% in 2022, its largest moves.
  • Tracing NCNA's Shares Outstanding (Entity) over 5 years: stood at $131.6 billion in 2018, then gained by 1.03% to $133.0 billion in 2019, then increased by 20.35% to $160.1 billion in 2020, then soared by 40.24% to $224.5 billion in 2021, then fell by 6.3% to $210.3 billion in 2022.
  • Business Quant data shows NCNA's Shares Outstanding (Entity) at $210.3 billion in Q2 2022, $224.1 billion in Q1 2022, and $224.5 billion in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6,012.74 Bn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 400.00 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 62.06 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 NuCana 14.60 Bn 14.60 Bn - 11.23 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 11.23 Bn
Sep 30, 2025 18.48 Bn
Jun 30, 2025 5.17 Bn
Mar 31, 2025 30.36 Bn
Dec 31, 2024 14.84 Bn
Sep 30, 2024 12.08 Bn
Jun 30, 2024 11.33 Bn
Mar 31, 2024 10.72 Bn
Dec 31, 2023 420.58 Mn
Sep 30, 2023 10.53 Bn
Jun 30, 2023 10.48 Bn
Mar 31, 2023 419.03 Mn
Dec 31, 2022 417.88 Mn
Sep 30, 2022 417.57 Mn
Jun 30, 2022 417.57 Mn
Mar 31, 2022 417.46 Mn
Dec 31, 2021 416.33 Mn
Sep 30, 2021 417.32 Mn
Jun 30, 2021 417.30 Mn
Mar 31, 2021 413.19 Mn